Cytokine-driven beta-cell production in vivo

Affiliations

¹ Center for Stem Cell Biology, Vanderbilt University, Nashville, Tennessee, USA, and in the Department of Cell and Developmental Biology, Vanderbilt University, Nashville, Tennessee, USA.
² 1] Center for Stem Cell Biology, Vanderbilt University, Nashville, Tennessee, USA, and in the Department of Cell and Developmental Biology, Vanderbilt University, Nashville, Tennessee, USA [2] Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee, USA.

Comment

Hannah N Worchel et al. Nat Biotechnol. 2014 Jan.

. 2014 Jan;32(1):63-4.

doi: 10.1038/nbt.2788.

¹ Center for Stem Cell Biology, Vanderbilt University, Nashville, Tennessee, USA, and in the Department of Cell and Developmental Biology, Vanderbilt University, Nashville, Tennessee, USA.
² 1] Center for Stem Cell Biology, Vanderbilt University, Nashville, Tennessee, USA, and in the Department of Cell and Developmental Biology, Vanderbilt University, Nashville, Tennessee, USA [2] Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee, USA.

No abstract available

Comment on

Transient cytokine treatment induces acinar cell reprogramming and regenerates functional beta cell mass in diabetic mice.
Baeyens L, Lemper M, Leuckx G, De Groef S, Bonfanti P, Stangé G, Shemer R, Nord C, Scheel DW, Pan FC, Ahlgren U, Gu G, Stoffers DA, Dor Y, Ferrer J, Gradwohl G, Wright CV, Van de Casteele M, German MS, Bouwens L, Heimberg H. Baeyens L, et al. Nat Biotechnol. 2014 Jan;32(1):76-83. doi: 10.1038/nbt.2747. Epub 2013 Nov 17. Nat Biotechnol. 2014. Retraction in: Nat Biotechnol. 2020 Mar;38(3):374. doi: 10.1038/s41587-020-0426-2. PMID: 24240391 Free PMC article. Retracted.